Joseph R. Young - 05 Jul 2023 Form 4 Insider Report for Vera Therapeutics, Inc. (VERA)

Role
SVP, Finance, Chief Acct Offcr
Signature
/s/ Joseph R. Young
Issuer symbol
VERA
Transactions as of
05 Jul 2023
Net transactions value
+$39,396
Form type
4
Filing time
06 Jul 2023, 16:05:49 UTC
Previous filing
17 Feb 2023
Next filing
18 Jan 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VERA Class A Common Stock Options Exercise $39,396 +10,000 +44% $3.94 32,679 05 Jul 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VERA Stock Option (right to buy) Options Exercise $0 -10,000 -13% $0.000000 66,810 05 Jul 2023 Class A Common Stock 10,000 $3.94 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/4 of the shares subject to the option vested on March 9, 2022, and 1/48 of the shares vest monthly thereafter.